4 free views remaining today
autosomal dominant intellectual developmental disorder 55
Description
Autosomal dominant intellectual developmental disorder 55, also known as MRD55, is a genetic condition characterized by global developmental delay and impaired intellectual development.
- Global developmental delay refers to a significant delay in the achievement of motor or mental milestones in children, including motor skills, speech and language, cognitive skills, and social-emotional development [1].
- Impaired intellectual development can manifest as below-average general intelligence quotient (IQ) scores, which may range from mild to severe impairment [2].
- Additional features associated with MRD55 include behavioral abnormalities, such as autism spectrum disorder (ASD) and attention deficit-hyperactivity disorder (ADHD), language delays, and other developmental challenges [3].
It's essential to note that the severity and specific symptoms of MRD55 can vary significantly among individuals. Some people may experience more pronounced intellectual disability, while others might have milder impairments.
The prevalence of autosomal dominant ID, including MRD55, is estimated to be relatively low in Western populations, with a range of 0.05 to 1.55% [4]. However, this figure can vary depending on the specific condition and population being studied.
It's also worth mentioning that MRD55 is often inherited in an autosomal dominant pattern, meaning that only one copy of the mutated gene is needed to cause the disorder [5].
References: [1] - Context 3 [2] - Context 5 [3] - Context 15 [4] - Context 11 [5] - Context 7
Additional Characteristics
- Global developmental delay
- Impaired intellectual development
- Behavioral abnormalities (autism spectrum disorder, attention deficit-hyperactivity disorder)
- Language delays
- Developmental challenges
Signs and Symptoms
Based on the available information, here are the signs and symptoms associated with autosomal dominant intellectual developmental disorder 55 (MRD55):
- Global developmental delay: MRD55 is characterized by global developmental delay, which means that affected individuals may experience delays in various aspects of development, such as cognitive, motor, and language skills [1].
- Impaired intellectual development: Individuals with MRD55 may have impaired intellectual development, which can manifest as mild to moderate intellectual disability or learning problems [2].
- Unique personality characteristics: Some people with MRD55 may exhibit unique personality characteristics, although the specific nature of these traits is not well-defined in the available information.
- Behavioral abnormalities: Behavioral abnormalities, such as autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD), have been associated with MRD55 [3].
- Language delay: Language development may be delayed or impaired in individuals with MRD55.
It's essential to note that the specific signs and symptoms of MRD55 can vary widely among affected individuals, and not everyone will exhibit all of these characteristics. If you're looking for more detailed information on this topic, I'd be happy to try and help you find it!
Additional Symptoms
- Global developmental delay
- Impaired intellectual development
- Unique personality characteristics
- Language delay
- Behavioral abnormalities (including autism spectrum disorder and attention deficit hyperactivity disorder)
Diagnostic Tests
Based on the provided context, here are some diagnostic tests that may be relevant for autosomal dominant intellectual developmental disorder:
- Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member [4].
- Chromosomal microarray analysis can be used to identify genetic variants associated with intellectual disability [5].
- Testing for fragile X syndrome, which is a common cause of inherited intellectual disability, may also be considered [5].
- Karyotype analysis and metabolic testing may also be performed as part of the diagnostic evaluation [5].
It's worth noting that the specific diagnostic tests used will depend on the individual case and may involve a combination of these approaches.
References: [4] - Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member. [5] - by P Pivalizza · Cited by 16 — - Rationale for genetic testing · - Chromosomal microarray analysis · - Testing for fragile X syndrome · - Karyotype analysis · - Metabolic testing ...
Additional Diagnostic Tests
- Metabolic testing
- Karyotype analysis
- Prenatal diagnosis
- Chromosomal microarray analysis
- Testing for fragile X syndrome
Treatment
Based on the search results, it appears that there are limited resources available for autosomal dominant intellectual developmental disorder-55 (MRD55). However, I can provide some general information about drug treatment options for related conditions.
- Risperidone is a well-documented treatment of disruptive, aggressive, and self-injurious behaviors in children with intellectual development disorders [4]. While this may not be specific to MRD55, it suggests that risperidone could potentially be used as a treatment option.
- The Orphanet summary for autosomal dominant intellectual developmental disorder-6 (MRD6) mentions pharmacotherapeutic strategies under development, but does not provide specific details about drug treatments [2]. This implies that there may be ongoing research into developing effective treatments for MRD55 and related conditions.
It's essential to note that these are general statements and not specific to MRD55. More research is needed to determine the most effective treatment options for this condition.
References: [1] Not applicable [2] by H El Mouhi · 2023 · Cited by 1 — Autosomal dominant intellectual development disorder-6 (MRD6) is a neurodevelopmental disorder caused by a genetic mutation in the grin2b gene. [4] Risperidone is a well-documented treatment of disruptive, aggressive, and self-injurious behaviors in children with intellectual development disorder with good ... [5] Not applicable
Recommended Medications
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for autosomal dominant intellectual developmental disorder (ADIDD) involves considering various other conditions that can present with similar symptoms.
According to the provided context, the differential diagnosis includes:
- All other syndromes associated with neurodevelopmental disorders [6]
- Seizures
- Obesity
- Behavioral disturbances
- Other autosomal dominant disorders such as achondroplasia, some forms of amelogenesis imperfecta, and Marfan syndrome [3]
Additionally, the context mentions that the differential diagnosis also includes other syndromes associated with intellectual disability and developmental delay, such as:
- MRD6, an autosomal dominant neurodevelopmental disorder characterized by delayed psychomotor development and intellectual disability of variable severity [2]
- Cohen syndrome, a rare genetic disorder marked by multi-systemic involvement, causing developmental delays, intellectual disabilities, microcephaly, and other symptoms [10]
It's worth noting that the differential diagnosis for ADIDD is extensive and requires careful consideration of various conditions to ensure accurate diagnosis.
References: [1] Not applicable [2] Context #2 [3] Context #3 [6] Context #6 [10] Context #10
Additional Differential Diagnoses
- Seizures
- Other syndromes associated with neurodevelopmental disorders
- Behavioral disturbances
- Autosomal dominant disorders (e.g. achondroplasia, amelogenesis imperfecta, Marfan syndrome)
- Intellectual disability and developmental delay syndromes (e.g. MRD6, Cohen syndrome)
- obesity
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080227
- core#notation
- DOID:0080227
- oboInOwl#hasDbXref
- MIM:617831
- rdf-schema#label
- autosomal dominant intellectual developmental disorder 55
- oboInOwl#hasExactSynonym
- autosomal dominant mental retardation 55
- IAO_0000115
- An autosomal dominant intellectual developmental disorder that is characterized by onset of myoclonic seizures in the first years of life, global developmental delay, intellectual disability, speech delay and ataxic gait that has_material_basis_in heterozygous mutation in the NUS1 gene on chromosome 6q22.
- rdf-schema#subClassOf
- t353685
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000147
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2597
- owl#annotatedSource
- t353703
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.